Clinical and Experimental Reproductive Medicine (CERM) is a premier journal dedicated to advancing the field of reproductive medicine. Published by the Korean Society of Reproductive Medicine, it aims to disseminate high-quality research and innovative clinical practices in reproductive health and medicine. With its Q3 ranking in reproductive medicine for 2023, CERM is positioned as a significant resource for researchers and practitioners seeking to stay current with the latest developments and findings in the field. Since its inception in 2011, CERM has provided a vital platform for original research articles, review papers, and case studies that cover a range of topics, including fertility treatments, reproductive endocrinology, and embryology. Researchers benefit from its accessibility, inspiring new insights and evidence-based approaches to clinical practices. Based in South Korea, its rigorous peer-reviewed publication process ensures that all contributions meet high academic standards, making it an invaluable asset for anyone engaged in reproductive health research or practice.

Gynakologische Endokrinologie is a pivotal journal published by SPRINGER HEIDELBERG, dedicated to advancing the fields of endocrinology, obstetrics, gynecology, reproductive medicine, and pediatrics. With an ISSN of 1610-2894, this journal serves as a valuable platform for researchers and practitioners to disseminate their findings and explore emerging trends and treatments in the realm of women's health and endocrine disorders. Though currently positioned in the Q4 quartile across relevant categories, its mission is to foster scholarly discourse that bridges gaps in knowledge and enhances clinical practices. With a commitment to quality research, it provides a forum for innovative studies and case reports that could influence future healthcare strategies. Positioned in Germany, Gynakologische Endokrinologie aims to cater to a global audience, enhancing knowledge and collaboration in critical areas impacting women's health and hormone-related conditions.

Gynakologie is a specialized academic journal published by Springer Heidelberg, focusing on the dynamic field of obstetrics and gynecology. With an ISSN of 2731-7102 and an E-ISSN of 2731-7110, the journal aims to provide a platform for innovative research and discussions that contribute significantly to women's health. Launched in 2022 and set to converge by 2024, it has quickly established itself within the academic community, currently ranking in the Q4 category in Obstetrics and Gynecology as per the 2023 quartile assessments. Despite its current positioning, the journal is dedicated to enhancing visibility and scholarly impact in this essential medical field. Published in Germany, it plays an important role in disseminating valuable insights and findings among researchers, clinicians, and students alike, thus fostering a better understanding of women's health issues. While the journal currently lacks open access options, it remains committed to contributing to the body of knowledge and advancing practices that benefit patients worldwide.

SEMINARS IN REPRODUCTIVE MEDICINE is a leading peer-reviewed journal dedicated to exploring the complexities of human reproduction, offering insightful perspectives that encompass advances in reproductive endocrinology, obstetrics, and gynecology. Published by THIEME MEDICAL PUBL INC, this esteemed journal holds a notable spot in multiple Scopus categories, ranking 21st in Reproductive Medicine and 38th in Obstetrics and Gynecology, with an impressive impact in the Q1 and Q2 quartiles. With its commitment to high-quality research and clinical implications, the journal serves as a vital resource for practitioners, researchers, and students alike, fostering an environment of innovation and collaboration in the rapidly evolving reproductive health landscape. SEMINARS IN REPRODUCTIVE MEDICINE also offers convenient open access options, ensuring that its contributions are readily available to the global academic community. For over two decades, from its establishment in 1999 to the present, it has retained a pivotal role in disseminating critical findings that inform both clinical practice and future research efforts.

Human Reproduction Open, published by Oxford University Press, is a prestigious open-access journal dedicated to advancing the field of reproductive health and medicine since its inception in 2017. With an E-ISSN of 2399-3529, the journal provides a vital platform for researchers, clinicians, and academics to disseminate innovative findings in obstetrics, gynecology, and reproductive medicine. It is recognized for its impactful contributions, holding an impressive rank of #3 out of 209 in Medicine - Obstetrics and Gynecology, #2 out of 90 in Medicine - Reproductive Medicine, and #1 out of 21 in Medicine - Embryology, placing it in the top percentiles of its respective categories. The open-access model ensures that research is freely accessible, fostering collaboration and knowledge sharing among professionals and students alike. With a commitment to high-quality, peer-reviewed publications, Human Reproduction Open plays a crucial role in shaping the future of reproductive health research and practice, serving as an essential resource for those dedicated to improving outcomes in this dynamic field.

Jornal Brasileiro de Reprodução Assistida is a prominent academic journal focusing on the latest advancements in reproductive medicine, published by the Sociedade Brasileira de Reprodução Assistida (SBRA). With an ISSN of 1517-5693 and an E-ISSN of 1518-0557, this journal has established itself as a vital resource for researchers, healthcare professionals, and students in the fields of obstetrics and gynecology. Notably recognized within the Q2 category for Obstetrics and Gynecology, it ranks #91 out of 209 in Scopus, placing it in the 56th percentile among its peers. The journal serves as a platform for disseminating innovative research and clinical practices related to assisted reproduction, fostering collaboration and knowledge sharing among professionals in Brazil and beyond. Although currently not an open-access journal, it remains committed to enhancing the scientific discourse in reproductive health, reflecting its vision of supporting advances in healthcare through rigorous peer-reviewed studies. Explore the pivotal contributions made in this field from 2000 to the present, and stay abreast of transformative developments that are shaping reproductive science.

GYNECOLOGIC AND OBSTETRIC INVESTIGATION, published by KARGER, is an influential journal dedicated to advancing the fields of obstetrics and gynecology. With an ISSN of 0378-7346 and E-ISSN 1423-002X, this esteemed publication has been disseminating pivotal research since 1895 and continues to serve as an authoritative source through its convergence until 2024. Renowned for its rigorous adherence to academic standards, it stands in the Q2 category for both Obstetrics and Gynecology and Reproductive Medicine as of 2023, reflecting its quality and impact within the scientific community. With Scopus rankings highlighting its commendable positions—Rank #66 in Obstetrics and Gynecology and Rank #31 in Reproductive Medicine—it is an essential resource for researchers, professionals, and students alike, fostering a deeper understanding of women’s health issues and innovative care practices. Despite not being an open-access journal, its contributions significantly influence current and future directions in clinical and translational research.

Reproductive Biomedicine Online, published by Elsevier, is a leading peer-reviewed journal that has established itself as a pivotal resource in the fields of Developmental Biology, Obstetrics and Gynecology, and Reproductive Medicine. With an impressive Impact Factor and a Q1 ranking in its respective disciplines as of 2023, this journal provides a platform for innovative research and comprehensive reviews that contribute to advancements in reproductive healthcare. The journal boasts rigorous Scopus rankings, placing it within the top tiers of its categories, which underscores its significance in shaping contemporary biomedical inquiry. Although not open access, it remains widely accessible through institutional subscriptions, making its wealth of knowledge available to researchers, clinicians, and students alike. Since its inception in 2000, Reproductive Biomedicine Online has been committed to fostering a deeper understanding of reproductive processes and biomedicine, ensuring that its content remains relevant and impactful in addressing challenges in reproductive health, thereby championing exceptional scientific discourse.

Reproductive Biology and Endocrinology, published by BMC, is a distinguished open-access journal established in 2003, catering to researchers and professionals in the interdisciplinary fields of reproductive biology, endocrinology, and related biomedical sciences. With a notable impact in 2023, the journal has achieved Q1 rankings in Obstetrics and Gynecology, Reproductive Medicine, and Endocrinology, alongside a Q2 ranking in Developmental Biology, establishing itself as a pivotal source of high-quality research and insights. The journal's commitment to freely accessible research promotes knowledge dissemination across its domains, which is crucial for advancing understanding of reproductive health and endocrine mechanisms. With a robust Scopus ranking showcasing its relevance—17th out of 209 in Obstetrics and Gynecology, and 8th out of 90 in Reproductive Medicine—it serves as an essential resource for academics and clinicians alike, facilitating innovative research and fostering collaboration within the global scientific community.

Welcome to the Turkish Journal of Obstetrics and Gynecology, a premier publication dedicated to advancing the field of reproductive health and women's care. Published by GALENOS PUBL HOUSE since 2004, this journal serves as an essential resource for researchers, clinicians, and students interested in the latest developments in obstetrics and gynecology. With an impact factor that reflects its growing influence, the journal is currently classified in the Q3 quartile within its category, ranking 114 out of 209 in Scopus, placing it in the 45th percentile. Offering a truly Open Access platform, it provides a global audience with immediate access to critical research findings. The journal encompasses a broad scope of topics aimed at improving health outcomes for women, with a focus on evidence-based practice. In recent years, from 2016 to 2024, it has significantly contributed to the regional and international discourse in the field, making it an invaluable resource for practitioners and scholars alike. Join us in exploring the vital issues and innovations shaping obstetrics and gynecology today.